United Therapeutics (UTHR) total liabilities

Total liabilities · fiscal 2025
$783.80M

United Therapeutics (UTHR) had total liabilities of $783.80M at the end of fiscal 2025 (December 31, 2025). That is 14.8% lower than the $920.00M of fiscal 2024. Figures as of 19 Nov 2026, 02:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$783.80M
Change on fiscal 2024
−14.8%
Growth, 5 years
−8.5% a year
Growth, 10 years
+3.0% a year
Highest on record
$1.25Bfiscal 2022
Lowest on record
$387.65Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

United Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities shrank at a compound 8.5% a year; over ten years the rate was 3.0% a year. Across the 17 fiscal years on record (2009–2025), the highest was $1.25B in fiscal 2022 and the lowest $387.65M in fiscal 2009.

History · 17 fiscal years

Total liabilities by fiscal year

United Therapeutics total liabilities, year by year

United Therapeutics (UTHR) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$783.80M 14.8% down
2024$920.00M 22.2% down
2023$1.18B 5.3% down
2022$1.25B 3.1% up
2021$1.21B 0.8% down
2020$1.22B 7.7% up
2019$1.13B 91.0% up
2018$593.20M 21.8% down
2017$758.40M 63.7% up
2016$463.40M 20.7% down
2015$584.70M 5.5% down
2014$618.84M 21.0% down
2013$783.26M 47.3% up
2012$531.73M 4.8% down
2011$558.71M 4.1% up
2010$536.87M 38.5% up
2009$387.65M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of United Therapeutics and comparable companies
CompanyTotal liabilitiesFiscal year
STERIS STE$3.54B2026
Insmed INSM$1.53B2025
United Therapeutics UTHR$783.80M2025
Incyte INCY$1.79B2025
Viatris VTRS$22.48B2025
Tenet Healthcare THC$20.70B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on UTHR

United Therapeutics, figure by figure

United Therapeutics (UTHR) overview: price, valuation and scorecardAll health care companies by market value

United Therapeutics total liabilities: questions and answers

How large are United Therapeutics's total liabilities?

United Therapeutics (UTHR) had total liabilities of $783.80M at the end of fiscal 2025 (December 31, 2025). That is 14.8% lower than the $920.00M of fiscal 2024.

What is the growth rate of United Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities shrank at a compound 8.5% a year; over ten years the rate was 3.0% a year.

What are the highest and lowest total liabilities figures on record for United Therapeutics?

Across the 17 fiscal years on record (2009–2025), the highest was $1.25B in fiscal 2022 and the lowest $387.65M in fiscal 2009.

How is United Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For United Therapeutics it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “United Therapeutics (UTHR) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/UTHR/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.